Abstract:Background: Study found that glucocorticoids, as first-line treatments for asthma, fails to prevent asthma recurrence. Orosomucoid-like (ORMDL) 3 is associated to childhood asthma onset and involved in the inflammation and repair of airway epithelium. We explored the functional role of ORMDL3 in glucocorticoid treatment for childhood asthma. Methods: Mice were sensitized with Ovalbumin (OVA) and treated with Dexamethasone (Dex), followed by OVA challenge to establish a mouse model of asthma. Histopathological changes in lung tissues were observed by hematoxylin-eosin and masson staining. Human bronchial epithelial (16HBE-14 degrees) cells were transfected with ORMDL3 overexpression plasmid and siRNA-interleukin (IL)-33 alone or in combination, followed by Dex. Cell viability was measured by MTT assay. Cell migration was evaluated by wound healing assay. The expressions of E-cadherin and Vimentin and the activation of NF-kappa B and MAPK/ERK in 16HBE-14 degrees cells were assessed by Western blot. The expressions of ORMDL3 and IL-33 in lung tissues and 16HBE-14 degrees cells were analyzed by qRT-PCR or Western blot. Results: Dex treatment alleviated the histopathological abnormality and reversed the overexpressions of ORMDL3 and IL-33 in the lung tissues of asthmatic mice. Overexpressed ORMDL3 enhanced migration and viability, decreased E-cadherin level, increased the levels of IL-33 and Vimentin, and promoted the phosphorylation of NF-kappa B and MAPK/ERK in Dex-treated 16HBE-14 degrees cells, thus reversing the effect of Dex treatment. However, siRNA-IL-33 inhibited viability and migration, increased E-cadherin level, decreased Vimentin level, and suppressed the phosphorylation of NF-kappa B and MAPK/ERK, thus reversing the effect of overexpressed ORMDL3 in Dex-treated 16HBE-14 degrees cells. Conclusion: ORMDL3 overexpression helped airway epithelial cellrepairin asthma via regulating IL-33 expression.

ORMDL3 and Its Implication in Inflammatory Disorders

ORMDL3 contributes to the risk of atherosclerosis in Chinese Han population and mediates oxidized low-density lipoprotein-induced autophagy in endothelial cells

ORMDL3 Facilitates the Survival of Splenic B Cells via an ATF6α–Endoplasmic Reticulum Stress–Beclin1 Autophagy Regulatory Pathway

ORMDL3 regulates NLRP3 inflammasome activation by maintaining ER-mitochondria contacts in human macrophages and dictates ulcerative colitis patient outcome

Methylation Status of ORMDL3 Regulates Cytokine Production and P-Erk/mmp9 Pathway Expression

Signal transducer and activator of transcription 6 directly regulates human ORMDL3 expression.

ORMDL3 Modulates Airway Epithelial Cell Repair in Children with Asthma under Glucocorticoid Treatment Via Regulating IL-33.

ORMDL3 Regulates Poly I:C Induced Inflammatory Responses in Airway Epithelial Cells

Ceramide Imbalance and Impaired TLR4-Mediated Autophagy in BMDM of an ORMDL3-Overexpressing Mouse Model

ORMDL3 Promotes Angiogenesis in Chronic Asthma Through the ERK1/2/VEGF/MMP-9 Pathway

A Common Functional Variant at the Enhancer of the Rheumatoid Arthritis Risk Gene ORMDL3 Regulates Its Expression Through Allele-Specific JunD Binding

Association Between Peripheral Blood Mononuclear Cell ORMDL3 Expression and the Asthma Predictive Index in Preschool Children.

Characterization of a Novel Isoform of the Human ORMDL3 Gene.

Simultaneous deletion of ORMDL1 and ORMDL3 proteins disrupts immune cell homeostasis

E3 Ubiquitin Ligase Cbl-B Suppresses Human Ormdl3 Expression Through Stat6 Mediation

Leukocyte immunoglobulin-like receptor A3 is increased in IBD patients and functions as an anti-inflammatory modulator

The expression of ORMDL3 in murine asthma model and the effect of dexamethasone

STING Positively Regulates Human ORMDL3 Expression Through TBK1-IRF3-STAT6 Complex Mediation

Promoter Characterization and Role of Camp/pka/creb in the Basal Transcription of the Mouse ORMDL3 Gene

From gene identifications to therapeutic targets for asthma: Focus on great potentials of TSLP, ORMDL3, and GSDMB

Mechanisms elevating ORMDL3 expression in recurrent wheeze patients: role of Ets-1, p300 and CREB.